Epidemiological features of healthcare-associated Acinetobacter baumannii infections in Taiwan during 2008 − 2019

Background: Acinetobacter baumannii can reside in humans without causing infection or symptoms but can opportunistically cause community and nosocomial infections. Few studies from Taiwan have used national-level data to investigate antibiotic resistance rates of A. baumannii infections in the inten...

Full description

Bibliographic Details
Published in:	Journal of Medical Sciences
Main Authors:	Chi-Jeng Hsieh, Chia-Peng Yu, Chun-Yu Liang, Min-Tser Liao, Li-Chun Liu, Fu-Huang Lin
Format:	Article
Language:	English
Published:	Wolters Kluwer Medknow Publications 2023-01-01
Subjects:	acinetobacter baumannii carbapenem healthcare-associated infections
Online Access:	http://www.jmedscindmc.com/article.asp?issn=1011-4564;year=2023;volume=43;issue=2;spage=56;epage=62;aulast=Hsieh

Similar Items

Genomic epidemiology of Acinetobacter baumannii goes global
by: Santiago Castillo-Ramírez
Published: (2023-12-01)

Acinetobacter Baumannii – Virulence Factors and Epidemiology of Infections
by: Marszalik Anna, et al.
Published: (2021-12-01)

Phenotypic and molecular characterisations of carbapenem-resistant Acinetobacter baumannii strains isolated in Madagascar
by: Pierrette Landrie Simo Tchuinte, et al.
Published: (2019-02-01)

Carbapenem Resistant Acinetobacter baumannii: Current Status of Problem in a Tertiary Care Hospital, Jaipur
by: Ekadashi Rajni, et al.
Published: (2023-06-01)

The H-NS Regulator Plays a Role in the Stress Induced by Carbapenemase Expression in Acinetobacter baumannii
by: Fanny Huang, et al.
Published: (2020-08-01)

Detection of Clonal Relationship Between Carbapenem-resistant Acinetobacter baumannii Isolates in an University Hospital
by: Yasemin KIRIK, et al.
Published: (2021-12-01)

Hemorrhagic bronchitis caused by carbapenem-resistant Acinetobacter baumannii infection: A case report
by: Zifang Li, et al.
Published: (2024-01-01)

Prevalence of carbapenem resistance genes in Enterobacteriaceae, Pseudomonas aeruginosa, and Acinetobacter baumannii from meat samples
by: Maryam Rezaeian, et al.
Published: (2025-01-01)

Molecular characterisation of colistin and carbapenem-resistant clinical isolates of Acinetobacter baumannii from Southeast Europe
by: Ivana Goic-Barisic, et al.
Published: (2023-06-01)

High lethality rate of carbapenem-resistant Acinetobacter baumannii in Intensive Care Units of a Brazilian hospital: An epidemiologic surveillance study
by: Mariana Neri Lucas Kurihara, et al.
Published: (2022-04-01)

Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii group in Taiwan
by: Tran Lam Tu Quyen, et al.
Published: (2025-01-01)

Rapid detection of Acinetobacter baumannii and molecular epidemiology of carbapenem-resistant A.baumannii in two comprehensive hospitals of Beijing, China
by: Puyuan eLi, et al.
Published: (2015-09-01)

Risk factors for hospital infections caused by carbapanem-resistant Acinetobacter baumannii
by: Zorana M Djordjevic, et al.
Published: (2016-10-01)

Effectiveness of Colistin in carbapenem resistant Acinetobacter baumannii – A systematic review
by: Feroz Ahmed, et al.
Published: (2023-09-01)

Control of Healthcare-Associated Carbapenem-Resistant <i>Acinetobacter baumannii</i> by Enhancement of Infection Control Measures
by: Shuk-Ching Wong, et al.
Published: (2022-08-01)

Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii
by: Yu-Chia Hsieh, et al.
Published: (2020-01-01)

Epidemiological characteristics of carbapenem-resistant Enterobacteriaceae and carbapenem-resistant Acinetobacter baumannii in a tertiary referral hospital in Korea
by: Sollan Kang, et al.
Published: (2022-06-01)

Carbapenem-resistant Acinetobacter baumannii carrier detection: a simple and efficient protocol
by: Jonathan Lellouche, et al.
Published: (2024-04-01)

Indications of carbapenem resistance evolution through heteroresistance as an intermediate stage in Acinetobacter baumannii after carbapenem administration Indicações da evolução da resistência ao carbapenem através da heteroresistência como estágio intermediário no Acinetobacter baumannii após administração de carbapenem
by: Silvana Vargas Superti, et al.
Published: (2009-04-01)

Pharmacokinetic/pharmacodynamic (PK/PD) simulation for dosage optimization of colistin and sitafloxacin, alone and in combination, against carbapenem-, multidrug-, and colistin-resistant Acinetobacter baumannii
by: Vipavee Rodjun, et al.
Published: (2023-11-01)

First report of SPM metallo-β-lactamases producing Acinetobacter baumannii isolates in Morocco
by: Abdelhamid Massik, et al.
Published: (2022-08-01)

In Vitro and In Vivo Activity of AS101 against Carbapenem-Resistant <i>Acinetobacter baumannii</i>
by: Tsung-Ying Yang, et al.
Published: (2021-08-01)

Genotyping Analysis of Nosocomial Acinetobacter baumannii Strains
by: Solomenniy A.P., et al.
Published: (2015-11-01)

Acinetobacter baumannii Isolated from Lebanese Patients: Phenotypes and Genotypes of Resistance, Clonality, and Determinants of Pathogenicity
by: Elias Dahdouh, et al.
Published: (2016-11-01)

Carbapenem-resistant Acinetobacter baumannii and Ventilator-associated Pneumonia; Epidemiology, Risk Factors, and Current Therapeutic Approaches
by: Malihe Kazemi Najafabadi, et al.
Published: (2024-04-01)

Evaluation of synergistic effect of tazobactam with meropenem and ciprofloxacin against multi-drug resistant Acinetobacter baumannii isolated from burn patients in Tehran
by: Valadan Tahbaz, Sahel, et al.
Published: (2019-08-01)

Preoptimized phage cocktail for use in aerosols against nosocomial transmission of carbapenem-resistant Acinetobacter baumannii: A 3-year prospective intervention study
by: Li-Kuang Chen, et al.
Published: (2022-05-01)

Extensively drug-resistant Acinetobacter baumannii isolated in a university hospital: Role of inter-hospital transmission
by: Gonzalo Rivera, et al.
Published: (2016-01-01)

Antimicrobial Susceptibility Pattern of Acinetobacter Baumannii and Rate of Carbapenem Resistance at a Tertiary Care Hospital in Karachi
by: Shomaila Malik, et al.
Published: (2017-06-01)

Quantitative Proteomics to study Carbapenem Resistance in Acinetobacter baumannii
by: Vishvanath eTiwari, et al.
Published: (2014-09-01)

Gastrointestinal Colonization of Carbapenem-Resistant <i>Acinetobacter baumannii</i>: What Is the Implication for Infection Control?
by: Shuk-Ching Wong, et al.
Published: (2022-09-01)

Insights into the epidemiology, risk factors, and clinical outcomes of carbapenem-resistant Acinetobacter baumannii infections in critically ill children
by: Yufei Zhang, et al.
Published: (2023-11-01)

Epidemiology of Acinetobacter baumannii Infections in Siriraj Hospital 2002
by: Anuwat Keerasuntonpong
Published: (2007-08-01)

Unusual community-associated carbapenem-resistant Acinetobacter baumannii infection, Pennsylvania, USA
by: Mohamed H. Yassin, et al.
Published: (2020-01-01)

Clinical burden of Acinetobacter baumannii, including carbapenem-resistant A. baumannii, in hospitalized adult patients in the USA between 2018 and 2022
by: Thomas P. Lodise, et al.
Published: (2025-04-01)

Comparing core-genome MLST with PFGE and MLST for cluster analysis of carbapenem-resistant Acinetobacter baumannii
by: Tingting Li, et al.
Published: (2022-09-01)

Exploring the clinical outcomes and molecular characteristics of Acinetobacter baumannii bloodstream infections: a study of sequence types, capsular types, and drug resistance in China
by: Jiao Chen, et al.
Published: (2025-02-01)

Analysis of the Class 1 Integrons, Carbapenemase Genes and Biofilm Formation Genes Occurrence in Acinetobacter baumannii Clinical Isolates
by: Xiu Yu, et al.
Published: (2024-05-01)

Risk Factors for Development and Mortality of Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii
by: Li L, et al.
Published: (2024-12-01)

Carrimycin, as One of the Drugs in Combination Therapy, for the Treatment of Carbapenem-Resistant Acinetobacter Baumannii Infection
by: Du N, et al.
Published: (2024-08-01)